21 Jan Jupiter Life Sciences Consulting Announces Saleem J Shah as Partner
LONDON – Jan. 21, 2019 Jupiter Life Sciences Consulting, a global leader in market access and pricing strategy in the biopharmaceutical industry, are delighted to announce the appointment of Saleem J Shah (Sal) as Partner. Based in London, Sal will build and lead European operations, supporting Jupiter’s rapid geographic expansion and growing its advisory practice areas and payer network in the pharma and biotech industry.
Sal has over 20 years of experience across pharma and consultancy in a number of leadership roles within market access, commercialization strategy and real-world evidence (RWE) functions at Pfizer, Roche, Sanofi, IMS, and ICON. He is able to bring a unique perspective on value creation and value strategy for new and existing assets within the healthcare environment, at global and local levels. Sal has deep experience in asset valuation, global pricing, launch excellence, market access & commercialization strategy, RWE, organizational development, and acquisition integration, having been involved in bringing numerous biopharmaceuticals to market.
“The addition of Sal to the Jupiter team is a significant event for our company,” said Steve Slovick, CEO and Managing Partner, Jupiter Life Sciences Consulting. “Our goal is to be the leader in solving the most complex issues facing our clients, and the addition of Sal rounds out our senior team and highlights our commitment to the global marketplace.”
“Having managed global operations for years, we understand the importance of hiring the most innovative and creative people in the industry to lead our practice,” said Ted Sweeney, President and Managing Partner. “Sal’s background, within both industry and consulting, provides our clients the most comprehensive thinking and collaboration with a colleague who has experienced many of the same challenges they have in bringing assets to market.”
“The complimentary experiences of our senior team add significant value to pharma and biotech innovators” said Sal. “I am excited to be joining such an accomplished group with a proven track record of delivering high quality results”
About Jupiter Life Sciences Consulting
Jupiter is a global team of strategy experts with a shared passion for shaping value, navigating market access and optimizing price for pharma and biotech innovators. Jupiter’s leadership has contributed to the commercial success of 75 percent of the top performing drugs in the market. The firm operates with an employee-owned model that is unique in the industry.
Jupiter delivers proven market access, pricing and commercialization strategies, payer engagement solutions, and litigation support. Jupiter equips clients to realize optimal market access through a deep understanding of stakeholders’ sensitivities and deliverables that are actionable for specific needs.
To learn more about Jupiter Life Sciences Consulting, visit www.jupiterls.com